3D Body Surface Modeling for Scoliosis Monitoring

Adolescent Idiopathic Scoliosis Clinical Trial

Official title:

Prospective Validation of 3D Body Surface Modeling for Patient Monitoring in Adolescent Idiopathic Scoliosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05697939
• Other study ID #: 54100
• Status: Recruiting
• Start date: August 26, 2020
• Est. completion date: January 1, 2030

Study information

• Verified date: December 2023
• Source: Stanford University
• Contact: Kali R Tileston, MD
• Phone: (650) 497-8891
• Email: kluker[@]stanford.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a single center, prospective, non-randomized reproducibility study of the NSite device in patients undergoing evaluation for scoliosis. The NSite device is a pre-market, investigational device. The study will enroll 13 eligible patients, who will be scanned using the NSite device by 3 separate users in order to assess if the device generates similar results across users. This data will be used to support 510(k) submission.

Description:

The primary objective of this study is to validate the reproducibility of device output in multiple users in a clinical setting. Device output will be predicted probability of major curve magnitude (i.e., Cobb angle) greater than or equal to 20 degrees with 95% confidence interval. We will test whether users obtain similar device output when measuring the same participant (at least 2 scans required for analysis). After excluding bad quality scans, the measurements obtained by these different users (at least 2 users after excluding bad scans) on each study participant will then be compared to determine if they are congruent (having overlapping confidence intervals) or different. The percentage of participants for which users generated congruent predicted probabilities will be reported.

The NSite Scoliosis Assessment App is intended as a clinical decision support tool and requires interpretation by the healthcare professional. It is intended for use for children and adolescent patients 10 to 18 years old. It is for use by prescription only. The NSite Scoliosis Assessment App provides a calculated Asymmetry Index for patients with or at risk for scoliosis, which will yield an output of percentage risk of major curve magnitude (i.e., Cobb angle) greater than 20 degrees, with 95% confidence intervals.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 13
• Est. completion date: January 1, 2030
• Est. primary completion date: January 1, 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 18 Years

Eligibility

Inclusion Criteria:

• Ages 10 and 18 years old

• Referred for evaluation of or diagnosed of adolescent idiopathic scoliosis

Exclusion Criteria:

• Scoliosis caused by another condition (e.g., secondary scoliosis)

• Parents/guardians unable to consent

• English is not the primary language (to avoid miscommunication)

Related Conditions & MeSH terms

• Adolescent Idiopathic Scoliosis
• Scoliosis

Intervention

Diagnostic Test:
• NSite 3D Scanning
Three separate users will enter the exam room and use the NSite application to scan the patient in the bending position. These users may include research coordinators, physicians, or other authorized staff. The NSite application will have a user tutorial on how to scan patients that users are instructed to watch prior to conducting a scan. All participants are asked to remove clothing above the waist but may keep a bra or tight-fitting shirt on during the scanning procedures. The patient will be asked to assume a forward bending position. One user will capture a scan of the patient's back in this position. The user will calibrate the device and then walk around the patient while scanning per app directions. Once this user captures the scan, it will be processed by the application. New scans will then be obtained by the two other users. Once all users have captured a scan, the scanning process and patient participation will be completed.

Locations

Country	Name	City	State
United States	Lucille Packard Children's Hospital and Clinics	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess the reproducibility of NSite device	Percentage of scan outputs reproducible. The percentage of scan sets (3 scans for each participant) that have reproducible predicted probabilities for major curve magnitude = 20 degrees. A reproducible output will be defined as a scan set in which all scans have overlapping 95% confidence intervals for the predicted probability of major curve magnitude = 20 degrees.	Anticipated to take about one month in order to recruit, enroll, and scan 13 patients.
Secondary	User Feedback	User feedback will be collected throughout testing in the form of open-ended comments. These will be collated and reported.	Anticipated to take about one month in order to recruit, enroll, and scan 13 patients.